Skip to main content
SpringerLink
Log in

Management of Portal Vein Thrombosis in Liver Cancer

  • Chapter
  • First Online:
Portal Vein Thrombosis

  • 559 Accesses

Abstract

Liver cancer can be diagnosed with portal vein thrombosis. Hepatocellular carcinoma is the most frequent primary liver cancer and in 10–40% of new diagnosis of PVT is described. Presence of PVT is associated with a poor prognosis. Different classifications have been proposed to identify potential surgical treatment. Contrariwise to the general recommendation, many centers apply different strategies to treat HCC with PVT. In this chapter, we will analyze the surgical and locoregional options for this patient. The role of downstaging therapy allowing a surgical curative treatment seems to be a more rising option.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277–87.

    Google Scholar 

  2. Minagawa M, Makuuchi M. Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol. 2006;12:7561–7.

    Article  CAS  Google Scholar 

  3. Cabibbo G, Enea M, Attanasio M, Bruix J, Craxi A, Camma C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology. 2010;51:1274–83.

    Google Scholar 

  4. Kumada K, Ozawa K, Okamoto R, et al. Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery. 1990;108:821–7.

    CAS  PubMed  Google Scholar 

  5. Shi J, Lai EC, Li N, et al. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. Ann Surg Oncol. 2010;17:2073–80.

    Article  Google Scholar 

  6. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, second English edition. Tokyo: Kanehara & Co., Ltd.; 2003.

    Google Scholar 

  7. Shuqun C, Mengchao W, Han C, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein. Hepato-Gastroenterology. 2007;54(74):499–502.

    PubMed  Google Scholar 

  8. Cheng S, Yang J, Shen F, et al. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus—Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget. 2016;7(26):40816–29. https://doi.org/10.18632/oncotarget.8386.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Kokudo T, Hasegawa K, Matsuyama Y, et al. Liver Cancer Study Group of Japan. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65:938–43.

    Article  Google Scholar 

  10. Jang TY, Huang CI, Yeh ML, Lin ZY, Chen SC, Chuang WL. The prognosis of bulky hepatocellular carcinoma with nonmajor branch portal vein tumor thrombosis. Medicine (Baltimore). 2019;98(13):e15066. https://doi.org/10.1097/MD.0000000000015066.

    Article  Google Scholar 

  11. Zhang ZY, Dong KS, Zhang EL, Zhang LW, Chen XP, Dong HH. Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(50):e18362. https://doi.org/10.1097/MD.0000000000018362.

    Article  Google Scholar 

  12. Lu J, Zhang XP, Zhong BY, et al. Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west. Lancet Gastroenterol Hepatol. 2019;4(9):721–30. https://doi.org/10.1016/S2468-1253(19)30178-5.

    Article  PubMed  Google Scholar 

  13. Levi Sandri GB, de Werra E, Mascianà G, et al. Laparoscopic and robotic approach for hepatocellular carcinoma-state of the art. Hepatobiliary Surg Nutr. 2016;5(6):478–84. https://doi.org/10.21037/hbsn.2016.05.05.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Levi Sandri GB, Ettorre GM, Aldrighetti L, et al. Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry. Surg Endosc. 2019;33(5):1451–8. https://doi.org/10.1007/s00464-018-6426-3.

    Article  PubMed  Google Scholar 

  15. Levi Sandri GB, Spoletini G, Vennarecci G, Francone E, Abu Hilal M, Ettorre GM. Laparoscopic liver resection for large HCC: short- and long-term outcomes in relation to tumor size. Surg Endosc. 2018;32(12):4772–9. https://doi.org/10.1007/s00464-018-6225-x.

    Article  PubMed  Google Scholar 

  16. Vennarecci G, Laurenzi A, Santoro R, Colasanti M, Lepiane P, Ettorre GM. The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion. World J Surg. 2014;38(6):1498–503.

    Article  Google Scholar 

  17. Vennarecci G, Ferraro D, Tudisco A, et al. The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience. Updat Surg. 2019;71(1):67–75. https://doi.org/10.1007/s13304-018-0596-3.

    Article  Google Scholar 

  18. Levi Sandri GB, Vennarecci G, Lepiane P, Ettorre GM. Associating liver partition and portal vein ligation for bleeding hepatocellular carcinoma in HBV cirrhosis: a safety strategy. Transl Gastroenterol Hepatol. 2017;2:20. https://doi.org/10.21037/tgh.2017.03.08.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Melandro F, Giovanardi F, Hassan R, et al. Minimally invasive approach in the setting of ALPPS procedure: a systematic review of the literature. J Gastrointest Surg. 2019;23(9):1917–24.

    Article  Google Scholar 

  20. Di Benedetto F, Assirati G, Magistri P. Full robotic ALPPS for HCC with intrahepatic portal vein thrombosis. Int J Med Robot. 2020;16(2):e2087. https://doi.org/10.1002/rcs.2087.

    Article  PubMed  Google Scholar 

  21. Bruix J, Cheng AL, Meinhardt G, Nakajima K, De Sanctis Y, Llovet J. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: analysis of two phase III studies. J Hepatol. 2017;67:999–1008.

    Article  CAS  Google Scholar 

  22. Zhang ZF, Luo YJ, Lu Q, Dai SX, Sha WH. Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: what is new? World J Clin Cases. 2018;6(9):259–73. https://doi.org/10.12998/wjcc.v6.i9.259.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wei X, Jiang Y, Zhang X, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study. J Clin Oncol. 2019;37:2141–51.

    Article  CAS  Google Scholar 

  24. Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, et al. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol. 2009;24:806–14.

    Article  Google Scholar 

  25. Chu HH, Kim JH, Shim JH, Yoon SM, Kim PH, Alrashidi I. Chemoembolization plus radiotherapy versus chemoembolization plus sorafenib for the treatment of hepatocellular carcinoma invading the portal vein: a propensity score matching analysis. Cancers (Basel). 2020;12(5):1116. https://doi.org/10.3390/cancers12051116.

    Article  CAS  Google Scholar 

  26. Kim PH, Choi SH, Kim JH, Park SH. Comparison of radioembolization and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis of safety and efficacy. Korean J Radiol. 2019;20(3):385–98. https://doi.org/10.3348/kjr.2018.0496.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Vouche M, Lewandowski RJ, Atassi R, et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013;59(5):1029–36. https://doi.org/10.1016/j.jhep.2013.06.015.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Tabone M, Calvo A, Russolillo N, Langella S, Carbonatto P, Lo Tesoriere R, Richetta E, Pellerito R, Ferrero A. Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience. J Gastrointest Oncol. 2020;11(1):84–90. https://doi.org/10.21037/jgo.2019.06.01.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Rotellar F, Zozaya G, Martí-Cruchaga P, Pardo F. Laparoscopic right hepatectomy after radioembolization using yttrium-90 resin microspheres. Surg Oncol. 2017;26(1):71–2. https://doi.org/10.1016/j.suronc.2016.12.004.

    Article  PubMed  Google Scholar 

  30. Tang K, Zhang B, Dong L, Wang L, Jin Y, Tang Z. Successful treatment of a huge hepatic carcinoma with right portal vein thrombosis: a case report. Medicine (Baltimore). 2020;99(17):e19636. https://doi.org/10.1097/MD.0000000000019636.

    Article  Google Scholar 

  31. Choi HS, Kang KM, Jeong BK, Jeong H, Lee YH, Ha IB, Song JH. Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease. Asia Pac J Clin Oncol. 2020 Aug 5. https://doi.org/10.1111/ajco.13361.

  32. Han B, Li C, Meng H, Gomes Romeiro F, Mancuso A, Zhou Z, Levi Sandri GB, Xu Y, Han T, Han L, Shao L, Qi X. Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population. Biosci Trends. 2019 Mar 14;13(1):10-22. https://doi.org/10.5582/bst.2018.01261.

Download references

Author information

Authors and Affiliations

  1. Division of General Surgery and Liver Transplantation, San Camillo Hospital, Rome, Lazio, Italy

    Giovanni Battista Levi Sandri

Authors
  1. Giovanni Battista Levi Sandri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Battista Levi Sandri .

Editor information

Editors and Affiliations

  1. Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China

    Xingshun Qi

  2. Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai, China

    Weifen Xie

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Levi Sandri, G.B. (2021). Management of Portal Vein Thrombosis in Liver Cancer. In: Qi, X., Xie, W. (eds) Portal Vein Thrombosis. Springer, Singapore. https://doi.org/10.1007/978-981-33-6538-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-33-6538-4_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-33-6537-7

  • Online ISBN: 978-981-33-6538-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation